Fidelity Investments’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-238,561
| Closed | -$9.46M | – | 5716 |
|
|
2024
Q1 | $9.46M | Buy |
238,561
+15
| +0% | +$443 | ﹤0.01% | 1880 |
|
|
2023
Q4 | $4.55M | Sell |
238,546
-226,266
| -49% | -$3.14M | ﹤0.01% | 2093 |
|
|
2023
Q3 | $5.32M | Sell |
464,812
-210,774
| -31% | -$2.59M | ﹤0.01% | 2023 |
|
|
2023
Q2 | $6.95M | Buy |
675,586
+674,330
| +53,689% | +$6.08M | ﹤0.01% | 1973 |
|
|
2023
Q1 | $9.7K | Buy |
1,256
+576
| +85% | +$4.59K | ﹤0.01% | 4141 |
|
|
2022
Q4 | $5K | Buy |
680
+478
| +237% | +$3.06K | ﹤0.01% | 4253 |
|
|
2022
Q3 | $1K | Buy |
202
+68
| +51% | +$560 | ﹤0.01% | 4771 |
|
|
2022
Q2 | $1K | Sell |
134
-132
| -50% | -$1.14K | ﹤0.01% | 4834 |
|
|
2022
Q1 | $2K | Buy |
+266
| New | +$2.3K | ﹤0.01% | 4732 |
|
|
2016
Q4 | – | Sell |
-25,000
| Closed | -$813K | – | 2725 |
|
|
2016
Q3 | $813K | Hold |
25,000
| – | – | ﹤0.01% | 2489 |
|
|
2016
Q2 | $460K | Hold |
25,000
| – | – | ﹤0.01% | 2554 |
|
|
2016
Q1 | $417K | Hold |
25,000
| – | – | ﹤0.01% | 2566 |
|
|
2015
Q4 | $774K | Hold |
25,000
| – | – | ﹤0.01% | 2556 |
|
|
2015
Q3 | $1.3M | Hold |
25,000
| – | – | ﹤0.01% | 2489 |
|
|
2015
Q2 | $1.51M | Buy |
+25,000
| New | +$1.49M | ﹤0.01% | 2487 |
|
Fidelity Investments's ALPN Position: Q2 2024 in Review
Fidelity Investments sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 238,561 shares — an estimated $9.46M sold.
Fidelity Investments first reported a position in ALPN in Q2 2015 and held it in 15 quarters. The position peaked at $9.46M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Fidelity Investments reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Fidelity Investments sold 238,561 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $9.46M.
- Fidelity Investments first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 15 quarters.
- Fidelity Investments's Alpine Immune Sciences Inc position peaked at $9.46M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.